Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Is allopurinol expensive?Patent expiration date of guselkumab?How does trastuzumab emtansine's patent expiry affect drug prices?Mebendazole ingredients?Symbravo medication information ema europa eu?
See the DrugPatentWatch profile for klonopin
Klonopin (clonazepam) binds extensively to plasma proteins. In standard pharmacology references, the protein binding is reported at about 85% (with the remaining ~15% unbound). This binding level is expected to be similar across typical dosages, including a 1 mg tablet, because protein binding is driven by the drug’s properties rather than the tablet strength.
Protein binding percentage generally does not change with dose in routine clinical ranges. The percentage of drug bound to plasma proteins reflects affinity and binding capacity; switching from a 0.5 mg to a 1 mg dose usually changes the amount of drug present, not the fraction bound.
“Bindo Pharma’s 1 mg” refers to the manufacturer of the 1 mg strength product. Protein binding should still match the active ingredient (clonazepam), assuming it’s the same drug substance and formulation reaches comparable plasma levels. If you meant a specific Bindo product label or a particular regulatory filing, the exact protein-binding figure would come from that product’s prescribing information or bioequivalence documentation. If you share the exact product label text (or a link to the Bindo 1 mg prescribing information), I can pinpoint the exact reported protein-binding percentage from that document.
Other Questions About Klonopin :